ReviewFrontiers in immunology2026

Immunomodulatory crosstalk between GPCR and hippo signaling in cancer: implications for tumor immunity and therapeutic targeting.

Xiangxiang Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.